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Abstract
Background: Hypoxia/reoxygenation(H/R)-induced apoptosis of cardiomyocytes plays an important role in myocardial
injury. Lycopene is a potent antioxidant carotenoid that has been shown to have protective properties on cardiovascular
system. The aim of the present study is to investigate the potential for lycopene to protect the cardiomyocytes exposed to
H/R. Moreover, the effect on mitochondrial function upon lycopene exposure was assessed.
Methods and Findings: Primary cardiomyocytes were isolated from neonatal mouse and established an in vitro model of H/
R which resembles ischemia/reperfusion in vivo. The pretreatment of cardiomyocytes with 5 mM lycopene significantly
reduced the extent of apoptosis detected by TUNEL assays. To further study the mechanism underlying the benefits of
lycopene, interactions between lycopene and the process of mitochondria-mediated apoptosis were examined. Lycopene
pretreatment of cardiomyocytes suppressed the activation of the mitochondrial permeability transition pore (mPTP) by
reducing the intracellular reactive oxygen species (ROS) levels and inhibiting the increase of malondialdehyde (MDA) levels
caused by H/R. Moreover, the loss of mitochondrial membrane potential, a decline in cellular ATP levels, a reduction in the
amount of cytochrome c translocated to the cytoplasm and caspase-3 activation were observed in lycopene-treated
cultures.
Conclusion: The present results suggested that lycopene possesses great pharmacological potential in protecting against
H/R-induced apoptosis. Importantly, the protective effects of lycopene may be attributed to its roles in improving
mitochondrial function in H/R-treated cardiomyocytes.
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Introduction
Myocardial infarction is the leading cause of premature death in
the United States and many developed countries [1,2]. Early
reperfusion after myocardial infarction is essential for reestablish-
ing the blood flow in order to prevent the myocardium from
further damage. Nevertheless, ischemia and reperfusion (I/R)-
injury is inevitable, which limits the myocardial salvage. Although
the exact mechanism is uncertain, several hypotheses have been
proposed to describe the pathogenesis of myocardial I/R-injury:
including oxygen radical hypothesis, calcium overload hypothesis
and inflammatory hypothesis [3]. As a result, the exploration for
a new intrinsic or exogenous method and potential therapeutic
agents that aims at reducing the I/R-injury has become an area of
intensive research.
Lycopene, a carotenoid compound, found naturally in tomato
and other fruits like papaya, pink guava and watermelon has long
been known for its health-promoting ability [4]. Among naturally
occurring carotenoids, lycopene has the strongest ability to
scavenge free radicals; being 10-fold, 47-fold and 100-fold more
effective at quenching singlet oxygen than a-tocopherol, b-
carotene and vitamin E respectively [5,6]. Thus, lycopene
treatment may represent a new therapeutic strategy in treating
ROS-related pathophysiological damage.
With the strong antioxidant property, lycopene has been shown
to have the ability to reduce the risk of cancers, such as breast,
prostate and pancreas cancer [7]. It also has protective effect in
various chronic conditions like cardiovascular disease (CVD),
coronary heart disease (CHD) and atherosclerosis [8,9,10]. In fact,
higher plasma lycopene concentration is associated with lower risk
of CVD in women which is mediated through the regulation of
cholesterol metabolism [11].
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Nevertheless, little is known about the role of lycopene in
cardioprotection and the underlying protective mechanisms
during I/R. Besides oxidative stress and apoptosis [12], mito-
chondria dysfunction [13,14] has been shown to exert a key role in
myocardial reperfusion injury. Therefore, the aims of the study
were to ascertain the protective effects of lycopene on H/R-
induced apoptosis and to assess whether the mitochondrial
dysfunction was involved in these effects.
In this study, we isolated primary cardiomyocytes from neonatal
mouse and established an in vitro model of hypoxia/reoxygena-
tion (H/R) which resembles I/R in vivo. Then we investigated the
effects of lycopene on H/R injury and discovered that lycopene




Cardiomyocytes were prepared from Neonatal C57BL/6 mice
(Animal Center of the Third Military Medical University,
Chongqing, China). This study was carried out strictly in
accordance with the recommendations in the Guide for the Care
and Use of Laboratory Animals of the National Institutes of
Health. The protocol was approved by the Committee on the
Ethics of Animal Experiments of the Third Military Medical
University (Permit Number: SYXK(CQ)2007-002). The neonatal
mice (1–3 day old) were disinfected with 70% ethanol and then
killed by decapitation. The chest was opened and the heart was
rapidly removed and placed in the cold CBFHH solution that
contains in mM: NaCl 145, D-Glucose 10, KCl 5.4, MgCl2?6H2O
1.2, Na-pyruvate 2, HEPES 10. These hearts were minced with
a fine forceps and collected. These tissue fragments were digested
by 0.1% trypsin (Hyclone, SH30042.01) for 10 min in a tube in
37uC water bath. After that, the cell suspension was centrifuged
(300 g for 8 min at 4uC). The supernatant was then removed and
the cell pellet was resuspended in M199 medium (HyClone
SH30253.01B) supplemented with 10% fetal bovine serum
(HyClone, Logan, UT, USA), 0.5 mM L-Glutamine (Japan,
B212), and 1% (v/v) streptomycin/penicillin (Beyotime, C0222).
These steps were repeated until the tissue fragments had
disappeared. The dissociated cells were replated in a culture flask
at 37uC for 1 h to enrich the culture with cardiomyocytes. The
nonadherent cardiomyocytes were collected and cells were
counted by TC10TM Automated cell counter (BIO-RAD Singa-
pore, 506BR3124) and then they were plated onto gelatin-coated
well plates. The cells were cultured in M199 medium supplemen-
ted with 10% fetal bovine serum, 0.5 mM L-Glutamine, 0.1 mM
Bromodeoxyuridine (Brdu) (Sigma, B5002) which was used to
prevent proliferation of cadiac fibroblast, and 1% (v/v) strepto-
mycin/penicillin in a 5% CO2-humidified atmosphere at 37uC.
The growth medium was changed on the following day with
a medium that did not contain Brdu.
Hypoxia/reoxygenation Treatment to Cardiomyocytes
Hypoxia/reoxygenation model was established according to the
methods previously described [15,16,17,18,19,20,21] with some
modifications. After 48–72 h, when the neonatal cardiomyocytes
of mice were cultured to 70% confluence in appropriate culture
dishes, they were pre-starved using M199 medium without fetal
bovine serum for 12 h. Then hypoxia was induced by replacing
the initial culture medium with DMEM without glucose and
serum, which was preflushed with a gas mixture (95% N2 and
5%CO2) for 15 min. Then cardiomyocytes were placed in
a modular incubator chamber (Billups Rothenberg, Inc., Del
Mar, CA) and were flushed with the gas mixture of 5% CO2–95%
N2 for 60 min. After that, the sealed chamber was placed into
a 37uC incubator. After hypoxia incubation, the cells were
provided with fresh normal medium and then restored to 95% air
and 5% CO2 for reoxygenation. For lycopene treatment, lycopene
(Sigma–Aldrich) was dissolved in a tetrahydrofuran (THF) solution
containing 0.025% butylated hydroxytoluene (BHT) to inhibit
formation of peroxides. This stock solution was prepared with
minimal exposure to air and light and stored at 270uC. 4 h prior
to the H/R treatment, THF-lycopene aliquots from the stock
solution were added to the culture medium to the indicated final
concentration. The THF was added in control and H/R groups.
The amount of THF Vehicle in the culture medium was 0.05%
(V/V), a concentration that did not affect the assays as evidenced
by comparisons with vehicle-free control medium.
Viability Assay
Cell viability was assessed with the Trypan blue staining
viability test as described previously [22,23,24] with some
modifications. Briefly, the culture medium was removed and
transferred to containers. The cells were digested by 0.25%
Trypsin (5 min at 37uC). Then, the removed medium was given
back to each well to terminate the digestion and the cell
suspensions were centrifuged at 300 g for 15 min at 4uC. The
pellets were resuspended in 0.4% Trypan blue solution (Sigma)
and incubated for 5 min at 37uC. Both the stained dead cells and
the unstained viable cells were counted by cell counter. The cell
viability was quantified as the percent of unstained cells over all
cells.
TUNEL Assay for Apoptosis
According to our previous experiments [25,26], the terminal
deoxynucleoitidyl transferase-mediated biotinylated UTP nick end
labeling (TUNEL) assay was performed using an in situ cell death
detection kit (Roche, USA). The cardiomyocytes on coverslips
were rinsed in phosphate-buffered saline (PBS), pH7.4 and
subsequently fixed for 60 min in 4% paraformaldehyde, pH 7.4,
at room temperature. After being rinsed twice in PBS, the
cardiomyocytes were permeabilized with 0.1% TritonX-100 in
0.1% sodium citrate for 10 min at room temperature. The
cardiomyocytes were rinsed two times in PBS again and then
apoptotic cells were detected by TUNEL staining following the
manufacturer’s instructions. At last, cardiomyocytes were counter-
stained with Hoechst33342 (5 min, at room temperature)
(Beyotime, China). TUNEL-positive nuclei were counted in four
nonoverlapping fields per coverslip, and then were converted to
percentage by comparing TUNEL-positive counts with the total
cell nuclei determined by Hoechst33342 counterstaining. Assay
was performed in a blinded manner and the experiment was
repeated for three times.
Assay of Intracellular Reactive Oxygen Species (ROS) and
Malondialdehyde (MDA) Levels
The determination of intracellular oxidant production was
based on the oxidation of 29, 79-dichlorouoresce in diacetate
(DCFH-DA) (Beyotime, China). Cardiomyocytes were seeded into
a 96-plate at a density of 16105/well. Following the treatment of
H/R, cells were incubated with DCFH-DA at 37uC for 20 min.
The uorescence was read at 485 nm for excitation and 530 nm for
emission with an InfiniteTM M200 Microplate Reader (Tecan,
Ma¨nnedorf, Switzerland). Then, cells were counted in each group
in five nonoverlapping fields randomly to normalize the fluores-
cence intensity. The amount of emitted fluorescence was
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correlated with the quantity of ROS in the cell. The experiment
was repeated for three times, and cellular uorescence intensity was
expressed as the fold change to the control group.
The intracellular MDA levels were measured using a Lipid
Peroxidation MDA Assay Kit (Beyotime, China) following the
manufacturer’s instructions. First, 16106 cardiomyocytes were
seeded in a 6-well plate. After H/R treatment, cardiomyocytes
were collected and lysed by cell lysis buffer and centrifuged at
10,000 g for 15 min. The supernatants were reacted with the
thiobarbituric acid (TBA), and the reaction products were
measured spectrophotometrically at 535 nm. The experiment
was repeated for three times, and the MDA levels were expressed
as nmol/mg protein.
Measurement of Mitochondrial Membrane Potential
The fluorescent, lipophilic and cationic probe, JC-1 (Beyotime,
China), was employed to measure the mitochondrial membrane
potential (DYm) of cardiomyocytes according to the manufac-
turer’s directions which has been described previously [27].
Briefly, after indicated treatments, cardiomyocytes were loaded
with JC-1 for 30 min at 37uC, and images were obtained by using
a Leica confocal laser scanning microscope (TCS SP2, Germany).
Images of the intensities of the green (JC-1 monomer) and red (JC-
1 aggregate) uorescence intensities were monitored within the
individual cells by emission wavelength at 530 nm and 590 nm.
Colocalization appeared as an orange red color because of the
mixing of the red and yellow signals. Green and red uorescence
intensities were detected using an InfiniteTM M200 Microplate
Reader. The DYm of cardiomyocytes in each treatment group
was calculated as the uorescence ratio of red to green and was
expressed as a multiple of the level in the control groups. As
a positive control, mitochondria were depolarized by treating
cardiomyocytes with 50 mM carbonylcyanidem-chlorophenyl-
hydrazone (CCCP) at 37uC for 5 min. All experiments were
repeated at least three times.
Detection of Cellular ATP Levels
Cellular ATP levels were measured using a firefly luciferase-
based ATP assay kit (Beyotime, China) according to the
manufacturer’s instructions. After the indicated treatments,
cardiomyocytes were lysed and centrifuged at 12,000 g for
5 min. Supernatants (100 mL ) were mixed with 100 mL of ATP
detection working dilution in a white 96-well plate. Luminance
(RLU) was measured by using an InfiniteTM M200 Microplate
Reader. Standard curves were also generated and the protein
concentration of each treatment group was determined using the
Bradford Protein assay. Total ATP levels were expressed as nmol/
mg protein. This experiment was repeated for three times.
Detection of Mitochondrial Permeability Transition Pore
(mPTP) Opening
The opening mPTP of cardiomyocytes were detected by using
the calcein–cobalt with a mPTP assay kit (Genmed Scientifics Inc.,
USA) according to the manufacturer’s directions as described
previously [28]. Briefly, cardiomyocytes, seeded in 24-well plates
(36105/per well), were washed with Reagent A, then incubated
with Reagents B and C (1:50; 500 mL per well) at 37uC for
20 min, then washed twice with Reagent A again. Fluorescence
intensity was measured using a InfiniteTM M200 Microplate
Reader (lex 488 nm, lem 505 nm). Cells were subsequently lysed
in 20 mL of 0.1 M NaOH and protein concentration was
measured using the Bradford Protein assay. The fluorescent
signals were normalized to total protein content in the correspond-
ing cell extract. Results were presented as normalized relative
uorescence units (NRFU; U/mg protein).
Immunocytochemical Analysis of Cytochrome c
After H/R treatment, cardiomyocytes were washed with PBS
and were stained for 30 min at 37uC with 250 nM mitochondria-
specific dye MitoTrackerRed (Molecular Probes, Cergy Pontoise,
France). Then, cardiomyocytes were washed with PBS and were
fixed with 4% paraformaldehyde for 20 min and permeabilized
with 0.1% Triton X-100 for another 10 min at room temperature.
The cells were incubated with 10% normal goat serum for 45 min.
Cells were then treated with anti-cytochrome c antibody (1:100;
Abcam, Cambridge, UK) overnight at 4uC. The cells were washed
with PBS twice and incubated with Alexa Fluor 488-conjugated
secondary antibody (1:100; Molecular Probes) for 1 h in the dark
at 37uC. After washing, the nucleus was counterstained with
Hoechst33342 for 10 min. Images of stained cells were obtained
by using a Leica confocal laser scanning microscope.
Measurement of Caspase-3 Activity
As described in detail previously in our experiments [25,26,29].
Cardiomyocytes caspase-3 activities were determined by using the
caspase-3 Activity Assay kit (Beyotime Institute of Biotechnology,
China) according to the manufacturer’s instructions. Results were
expressed as the change in enzyme activity relative to the control
cultures.
Statistical Analysis
All the experimental data were expressed as the mean 6 SEM.
Raw data was analyzed with the GraphPad Prism 5.0 software
(GraphPad Software, Inc., SanDiego, CA). Each experiment was
carried out at least three times. Statistical analysis for multiple
group comparisons was performed by one-way ANOVA, followed
by post hoc least significant difference (LSD) tests. All P values
were two sided, and P,0.05 was considered statistically signifi-
cant.
Results
Effect of Lycopene on the Loss of Cell Viability Induced
by H/R
After cardiomyocytes were exposed to various time of hypoxia
(1, 2, 4, 8, and 16 h), cell viability was assessed with the Trypan
blue staining viability test. We found that cell viability was
significantly decreased in a time-dependent manner relative to the
control group (Fig. 1A). Exposure to 2 h hypoxia reduced cell
viability to 92.7% compared with the control (P,0.05), while 4 h,
8 h, and 16 h of hypoxia reduced cell viability to 77.3%, 62.5%,
36.4% of the control respectively (P,0.01). The shortest time
tested, 1 h, did not induce a significant change in cell viability. In
addition, after 4 h hypoxia, the cardiomyocytes underwent
reoxygenation for 0, 2, 4, 8, and 16 h respectively. As shown in
Figure 1B, cell viability was significantly reduced to 70.6% after
8 h of reoxygenation (P,0.05) and 61.9% after 16 h of
reoxygenation (P,0.01) compared with the 0 h reoxygenation
group. Based on these results, treatment with 4 h hypoxia followed
by 8 h of reoxygenation was selected for experiments to examine
the potential of lycopene-mediated cardiomyocytes protection.
To investigate the possible cardiomyocytes protective effects of
lycopene on H/R injury, cardiomyocytes that were pretreated
with lycopene (0, 1.25, 2.5, 5, 10 and 20 mM, respectively) for 4 h
underwent H/R treatment. We found that pretreatment with 2.5,
5, and 10 mM lycopene could successfully attenuate the decrease
of cell viability caused by H/R treatment (Fig. 2A). The result
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suggested that lycopene exerted cardiomyocytes protection ability
against the H/R-injury in primary cultured mouse cardiomyo-
cytes.
Lycopene Reduces H/R-induced Apoptosis of Cultured
Cardiomyocytes
Morphological changes associated with H/R injury were
assessed qualitatively by the phase contrast microscopy (Fig. 3A).
Many cardiomyocytes were spreading and were simultaneously
beating in control cultures. In the H/R-treated cultures, however,
cardiomyocytes were rolling up and not beating. These H/R-
induced morphological alterations were prevented by the pre-
treatment with 5 mM lycopene. Then, we investigated the effect of
lycopene on the H/R-induced apoptosis in cultured the cardio-
myocytes using the TUNEL assay (Fig. 3B and C). More TUNEL-
positive cells (green) were observed in H/R-treated cultures
(Fig. 3B, top row). Quantitative analysis also showed that H/R
induced an increase in TUNEL-positive apoptotic cells compared
with cells under regular conditions (P,0.01), pretreatment with
5 mM lycopene reduced the amount of TUNEL-positive cells in
comparison to the H/R group (P,0.05; Fig. 3C).
Lycopene Reduced the H/R Mediated Oxidative Stress in
Primary Cultured Cardiomyocytes
In the H/R group, exposure to 4 h hypoxia followed by 8 h
reoxygenation significantly increased the production of ROS in
comparison to that of the control group and lycopene group
(P,0.01; Fig. 4A). However, the increased amount of ROS in the
H/R group could be reduced by pretreatment with lycopene
(P,0.05; Fig. 4A). These results indicated that H/R had the
ability to induce oxidative stress in the cardiomyocytes, however,
this effect could be reduced by lycopene pretreatment.
To determine the impact of H/R on oxidative lesions, the
intracellular levels of MDA (a common end product of lipid
peroxidation) were measured. MDA concentration was elevated
significantly in H/R-treated cells (p,0.05); however, pretreatment
with 5 mM Lycopene decreased H/R-induced MDA generation
(p,0.05) (Fig. 4B).
Lycopene Inhibits the Opening of mPTP
Our goal was to test whether the opening of mPTP can be
triggered during H/R and whether mPTP inhibition is a mecha-
nism for the protective effects of lycopene. We detected mPTP by
using the calcein–cobalt method to monitor the distribution of
green fluorescence emitted from calcein as readout of the intact
mPTP. A significant decrease in mitochondrial fluorescence of H/
Figure 1. Effects of H/R on cell viability in primary cultured cardiomyocytes. (A) Primary cultured cardiomyocytes were exposed to hypoxia
condition for different time (1, 2, 4, 8, 16 h). (B) After 4 h hypoxia, cardiomyocytes were exposed to reoxygenation condition for different time (0, 2, 4,
8, 16 h). After these exposures, cell viability was determined with Trypan blue staining. Data are expressed as percentage of control and represented
as mean 6 SEM for six independent experiments. *P,0.05, **P,0.01 versus hypoxia 0 h group, #P,0.05, ##P,0.01 versus reoxygenation 0 h
group.
doi:10.1371/journal.pone.0050778.g001
Figure 2. The protective effects of lycopene on H/R-injury.
Primary cultured cardiomyocytes were pretreated with lycopene (0,
1.25, 2.5, 5, 10, 20 mM, respectively) for 4 h underwent 4 h hypoxia,
then 8 h reoxygenation. *P,0.05, **P,0.01 versus 0 group. Values are
mean 6 SEM, n = 3.
doi:10.1371/journal.pone.0050778.g002
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R treated cardiomyocytes was observed compared to the control
group (P,0.01) (Fig. 5). However, lycopene pretreated cultures
group demonstrated a significantly higher level of the NRFU
compared with the H/R group (P,0.05). Taken together our
results demonstrate that lycopene has the ability to reduce the
extent of opened mPTP in response to H/R treatment.
Figure 3. Lycopene protects cultured cardiomyocytes against H/R-induced apoptosis. Cultured cardiomyocytes were treated with 5 mM
lycopene for 4 h prior to H/R treatment. (A) Effects of H/R on cardiomyocytes and protection by lycopene. Magnification: 2006. (B) Representative
images of TUNEL-positive cells (green, top row) and Hoechst33342 counterstaining (blue, middle row). Scale bar: 40 mm. (C) The histogram shows the
relative proportion of TUNEL-positive cells in the different treatment groups. **P,0.01 versus control group, #P,0.05 versus H/R group. Values are
mean 6 SEM, n = 3.
doi:10.1371/journal.pone.0050778.g003
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Lycopene Prevents Mitochondrial Dysfunction
To further investigate the effects of lycopene on the mitochon-
drial function, indicators of mitochondrial activity such as
membrane potential (DYm) and levels of cellular ATP were
determined. We estimated DYm by using the JC-1 probe. The JC-
1 probe detected both red polarized mitochondria and green
depolarized mitochondria in the control cells, which represented
the DYm under physiological conditions (Fig. 6A). H/R treated
cardiomyocytes showed a decrease in the red fluorescence and
a significant increase in the green fluorescence, and lycopene
pretreatment reversed the changes in fluorescence. The fluores-
cence ratio of red to green quantified the DYm, and a low ratio
represented mitochondrial depolarization. We also found that the
ratio of H/R group was lower than control (P,0.01) and lycopene
pretreatment showed the protective effects compared to the H/R-
treated groups (P,0.05; Fig. 6B). Cellular ATP content was also
a sensitive readout of mitochondrial function. As shown in Fig. 6C,
ATP concentrations significantly decreased from 9.30 nmol/mg
protein in the control group to 3.67 nmol/mg protein in the H/R
group (p,0.05). In contrast, pretreatment of cultures with
lycopene resulted in an increase of cellular ATP level compared
with H/R group (P,0.05). These findings provided evidences that
lycopene protected mitochondrial function during H/R.
Lycopene Blocks the Mitochondrial Apoptotic Pathway
Mitochondrial dysfunction may initiate apoptosis by releasing
pro-apoptotic factors, such as cytochrome c, from the mitochon-
drial intermembrane space into the cytoplasm to trigger apoptosis
via a caspase-3-dependent pathway [30,31]. Accordingly, changes
in mitochondrial cytochrome c were measured by simultaneous
the cytochrome c immunouorescence and MitoTracker Red
uorescence. As shown in Figure 7A, H/R treatment decreased
colocalization of cytochrome c and MitoTracker Red (peripheral
green uorescence, bottom row) which indicated the release of
cytochrome c from the mitochondrial matrix into the cytosol. This
subcellular shift in cytochrome c was markedly inhibited by 5 mM
lycopene pretreatment.
To further investigate the effects of Lycopene on caspase-3
activation, we measured caspase-3 activity (Figure 7B) by
a spectrophotometric assay in cell lysates from four different
groups. Cardiomyocytes with H/R treatment showed a significant
increase in caspase-3 activity (P,0.05). In contrast, pretreatment
with 5 mM lycopene significantly inhibited the H/R-induced
activation of caspase-3 (P,0.05), suggesting that the lycopene
reduced H/R-induced apoptosis was mediated through the
blockage of caspase-3-dependent cardiomyocytes apoptosis.
Discussion
In the present study, by using the primary cultured cardiomyo-
cytes, we confirmed that apoptosis was important in H/R-injury
[12]. Furthermore, the present result demonstrated that H/R-
induced apoptosis was closely associated with mitochondrial
dysfunction. Importantly, the H/R-induced apoptosis was effi-
ciently prevented by lycopene pretreatment. To our knowledge,
this is the first report to elucidate the cardiomyocytes protective
action of lycopene in cardiomyocytes in response to the H/R-
injury.
In the present study, the possible correlation between lycopene
and mitochondria function was evaluated. It is well known that
mitochondria are the key components to the function of
cardiomyocytes [32] and that mitochondrial dysfunction is the
primary cause of H/R-induced apoptosis of cardiomyocytes [17].
A critical factor mediating mitochondrial dysfunction is the
opening of mPTP. Upon activation of mPTP, functional
breakdown and morphological disintegration of mitochondria
Figure 4. Effects of lycopene on ROS generation and lipid
oxidation in cardiomyocytes. Pretreated with lycopene (5 mM) for
4 h, cells were exposed to H/R. (A) Intracellular ROS levels were
estimated using the probe DCFH-DA. Fluorescence was read at 485 nm
for excitation and 530 nm for emission with a uorescence microplate
reader. Cellular uorescence intensities were expressed as the multiple of
the level in the control groups. (B) Cellular MDA levels were measured
using the TBA method, and the concentrations of MDA were expressed
as nmol/mg protein. *P,0.05, **P,0.01 versus control group; #P,0.05
versus H/R group. Values are mean 6 SEM, n = 3.
doi:10.1371/journal.pone.0050778.g004
Figure 5. The influence of lycopene on the opening of mPTP in
cardiomyocytes exposed to H/R. The mPTP opening was assayed
using the calcein–cobalt quenching method. Different group of
cardiomyocytes were used to measure the normalized relative
fluorescence units (NRFU) of calcein. **P,0.01 compared to the control
group, #P,0.05 compared to the H/R group. Values are mean 6 SEM,
n = 3.
doi:10.1371/journal.pone.0050778.g005
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occurs and thus initiates cell death [13]. In this study, we further
confirmed that the anti-apoptotic action of lycopene was mediated
by suppressing the ROS dependent mPTP opening to prevent
mitochondrial dysfunction and blocked the activation of the
cytochrome c/caspase-3 apoptotic pathway.
The increased production of ROS mainly formed in the
mitochondrial respiratory chain could result in an oxidative
Figure 6. Effects of lycopene on the mitochondrial function in H/R-treated cells. Pretreated with Lycopene (5 mM) for 4 h, cells were
exposed to H/R. The treated cells were detected by confocal microscopy and a uorescence microplate reader. (A) Red fluorescence is from JC-1
aggregates in healthy mitochondria with polarized inner mitochondrial membranes, while green fluorescence is emitted by cytosolic JC-1 monormers
and indicates DYm dissipation. Merged images indicate the co-localization of JC-1 aggregates and monomers. Scale bar: 50 mm. (B)The DYm of the
cardiomyocytes in each group was calculated as the uorescence ratio of red to green, and they were expressed as the multiple of the level in control
groups. (C) Effects of lycopene on the ATP content in H/R-treated cells. ATP concentrations were determined using an ATP Determination Kit, and the
ATP levels were expressed as nmol/mg protein. *P,0.05, **P,0.01 versus control group; #P,0.05 versus H/R group. Values are mean 6 SEM, n= 3.
doi:10.1371/journal.pone.0050778.g006
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damage to mitochondrial proteins and DNA are highly relevant to
myocardial failure and atherosclerosis [33]. Moreover, ROS can
cause thiol oxidation and inhibition of the ATP synthesis and
adenine nucleotide translocate (ANT). They can also cause
peroxidation of the unsaturated fatty acids in membrane
phospholipids, especially cardiolipin at the inner mitochondrial
membrane, which leads to further inhibition of respiratory chain
activity [34,35]. As a consequence of lipid peroxidation, reactive
aldehydes such as 4-hydroxynonenal are released and can modify
membrane proteins [36]. In this study, we found that ROS levels
and lipid oxidation increased in H/R-treated cardiomyocytes, and
were effectively attenuated by lycopene. The anti-oxidative
potential of lycopene should be accounted for its ability to
preserve the activity of endogenous free radical scavengers, and
protect respiratory chain complexes directly [37], which prevents
ROS production and secondary oxidative damage.
It has been shown that an increase in intracellular ROS
predisposed cells to damage [3,38] and involved numerous
signaling pathways. Initiation of ROS-dependent mPTP opening
has specifically been implicated in cardiomyocytes death [39]. The
Figure 7. Lycopene inhibited H/R-induced cytochrome c release and caspase-3 activation in cardiomyocytes. (A) Lycopene inhibited H/
R-induced cytochrome c release. Pretreated with lycopene (5 mM) for 4 h, cells were exposed to H/R. The nucleus was stained with Hoechst33342.
Mitochondrial cytochrome c release was detected by colocalization of MitoTracker Red and cytochrome c (green) immunocytochemical signals under
confocal microscopy. Scale bar: 50 mm. Images presented are representative of three independent experiments. (B) Lycopene inhibited H/R-induced
caspase-3 activation. Cardiomyocytes were treated as described in (A). Caspase-3 activity was detected using a commercial kit as described in
Methods. Data are presented as fold-change from the control group. *P,0.01 versus control group. #P,0.05 versus H/R group. Values are mean 6
SEM, n = 3.
doi:10.1371/journal.pone.0050778.g007
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mPTP is located at the junction between the internal and outer
membranes of the mitochondria (intermembrane compartment/
space). The diameter of a mPTP allows molecules up to
,1500 Da to cross the mitochondrial membrane. During H/R,
the elevated cellular ROS levels, combined with the excessive
amounts of Ca2+ and adenine nucleotide depletion, trigger the
opening of mPTP [40]. Given the anti-oxidative ability, we
hypothesize that there was a role for lycopene in the regulation of
mPTP. This hypothesis was supported by the observation that
lycopene was able to partially inhibit the opening of mPTP and
decrease ROS levels in cardiomyocytes.
The opening of the mPTP can lead to a bioenergetic, bio-
synthetic, and redox crisis in a cell that can directly threaten the
survival of the cell [41]. When the mPTP is open, the
mitochondrial inner membrane becomes permeable to protons
which then lead to the uncoupling of the electron respiratory chain
and the collapse of membrane potential, which in turn leads to
a cessation of ATP generation in mitochondria [41,42]. In the
pretreated cardiomyocytes with lycopene, the H/R-induced loss of
mitochondrial membrane potential and decline in ATP levels were
alleviated, supporting the notion that the protection of cardio-
myocytes is, in part, due to the prevention of mitochondrial
dysfunction. These results were consistent with recent studies that
had demonstrated the ability of lycopene to enhance the
mitochondrial activity of HepG2 cells exposed to aflatoxin B1
[43] and to improve the mitochondrial function in nervous system
of rats exposed to 3-nitropropionic acid [37].
Another threatening consequence of the altered mitochondrial
permeability is the release of apoptogenic proteins from the
mitochondrial intermembrane space into the cytosol [41,42].
Cytochrome c is associated with the inner mitochondrial
membrane and serves as an essential component of the electron
transfer chain. With opening of the mPTP and translocation of
cytochrome c into the cytosol, mitochondrial function is compro-
mised. In this study, the release of cytochrome c from the
mitochondrial matrix into the cytosol was significantly inhibited by
the 5 mM lycopene pretreatment; the results of this study
demonstrated a correlation exists between lycopene and the
preservation of mitochondrial function. Moreover, once the
cytochrome c enters the cytosol, it becomes associated with the
apoptotic peptidase activating factor 1 (Apaf-1) and dATP in order
to form an apoptosome. Apoptosomes recruit and activate
procaspase-9, which in turn activates other downstream caspases
to initiate apoptosis [42]. Caspase-3 has classically been considered
as an executioner caspase. In this experiment, lycopene suppressed
the activation of caspase-3 and was associated with lowering the
cytosolic levels of cytochrome c. In addition, recent studies have
revealed that lycopene participates in the intrinsic apoptosis
process by inhibiting the mitochondrial apoptotic pathway [28].
Although the underlying mechanisms required further study, the
present study demonstrated that lycopene inhibits the intrinsic
signaling pathways of apoptosis.
In conclusion, mitochondrial dysfunction may be the underlying
cause of the H/R-induced apoptosis in mouse cardiomyocytes,
whereas lycopene may provide protective benefit by maintaining
the mitochondrial function. Interactions between lycopene and the
mitochondria provided a new strategy to protect against the H/R-
induced apoptosis by improving the mitochondrial function.
Future experiments are required to evaluate the protective efficacy
of lycopene in vivo, and the possible molecular mechanism will be
clarified.
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